MacroGenics Inc

The Biomedical Research Institute (BRI) is a nonprofit organization dedicated to advancing global health through infectious disease research and service activities, with a focus on diseases like schistosomiasis. With nearly 70 years of experience in cryobiology, BRI offers custom biorepository solutions that ensure secure and efficient storage of biomaterials for researchers worldwide. BRI operates the Schistosomiasis Resource Center (SRC), a National Institutes of Health-supported laboratory providing essential research reagents at no cost to the scientific community. By facilitating access to crucial resources such as infected hosts and various life cycle stages of Schistosoma spp., the SRC plays a vital role in advancing research efforts aimed at combating this deadly parasitic disease. Generated from the website

Sequella Inc. is a clinical-stage pharmaceutical company based in Rockville, MD, focused on developing innovative antibiotics to combat drug-resistant bacterial, fungal, and parasitic infections. Their product pipeline addresses significant global health threats, particularly tuberculosis and its multidrug-resistant forms, which impact billions of people worldwide. With two drug candidates having completed phase 2 clinical trials and additional candidates in preclinical development, Sequella aims to tackle various infectious diseases, including Helicobacter pylori infections and Clostridium difficile. Their research also explores treatments for non-tuberculous mycobacterial infections and parasitic diseases, demonstrating a commitment to addressing critical health challenges globally. Generated from the website

Bioqual Inc, based in Rockville, MD, is a fully accredited preclinical testing contract research organization specializing in infectious disease investigations, cancer research, and a wide range of in vivo and in vitro studies. With state-of-the-art facilities and a team of experienced research scientists, veterinarians, and animal care personnel, Bioqual collaborates with government, academic, and commercial organizations to provide innovative research support for improving global health. Founded by Dr. John C. Landon, Bioqual has a long history of conducting cutting-edge biomedical research, including the testing of vaccines and therapeutics for various infectious diseases such as COVID-19. The company's dedication to advancing scientific knowledge and its commitment to quality research have positioned Bioqual as a key player in the field of preclinical testing and research services.Generated from the website